Radioimmunoassay study of hepatic clearance and disappearance half-time of somatostatin and vasoactive intestinal peptide in dogs.
- 1 September 1981
- Vol. 22 (9), 732-737
- https://doi.org/10.1136/gut.22.9.732
Abstract
The effects of hepatic transit on concentrations of synthetic cyclic (ovine) somatostatin and of highly purified (porcine) vasoactive intestinal peptide were studied in five conscious dogs prepared with indwelling portal catheters. The peptides were infused via peripheral vein catheters or the portal catheters for 40 minutes at actual integrated doses of 2.8 pmol/kg/min for vasoactive intestinal peptide an 8.2 pmol/kg/min for somatostatin. Specific radioimmunoassays were used for the measurement of the circulating peptides. As estimated from the plateau peptide concentrations achieved a hindleg vein during the portal and the peripheral infusions, the transhepatic loss of immunoreactive vasoactive intestinal peptide was 72.9 +/- 2.1%, against 27.5 +/- 12.5% for somatostatin. For the given doses of peptides infused systematically, the half-life, metabolic clearance rate, and distribution volume were, respectively, 1.80 +/- 0.1 minutes, 39.3 +/- 5.2 ml/kg/min, and 103.7 +/- 14.8 ml/kg for vasoactive intestinal peptide, and 1.0 +/- 0.2 minutes, 95.2 +/- 12.5 ml/kg/min, and 114.7 +/- 6.0 ml/kg for somatostatin. These results indicate that (ovine) somatostatin and (porcine) vasoactive intestinal peptide are both readily cleared from plasma in dogs. In the present experimental conditions, vasoactive intestinal peptide, but not somatostatin, was rapidly altered through hepatic transit so that it escaped recognition by the assay system.This publication has 24 references indexed in Scilit:
- Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.Gut, 1978
- Pancreatic and Gastric Somatostatin Release in Response to Intragastric and Intraduodenal Nutrients and HCl in the DogJCI Insight, 1978
- Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin.Gut, 1978
- Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gutCell and tissue research, 1977
- Synthesis and pharmacological properties of the N-terminal decapeptide of the vasoactive intestinal peptide (VIP)Journal of Medicinal Chemistry, 1977
- Suppression of Gastrin Release and Gastric Secretion by Gastric Inhibitory Polypeptide (GIP) and Vasoactive Intestinal Polypeptide (VIP)Annals of Surgery, 1976
- POSSIBLE DUAL ROLE FOR VASOACTIVE INTESTINAL PEPTIDE AS GASTROINTESTINAL HORMONE AND NEUROTRANSMITTER SUBSTANCEThe Lancet, 1976
- Vasoactive Intestinal Polypeptide: Inactivation in Liver and Potentiation in Lung of Anesthetized DogsExperimental Biology and Medicine, 1975
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973
- Isolation from Porcine‐Intestinal Wall of a Vasoactive Octacosapeptide Related to Secretin and to GlucagonEuropean Journal of Biochemistry, 1972